Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Endocrinology
Volume 2016, Article ID 7974182, 5 pages
http://dx.doi.org/10.1155/2016/7974182
Case Report

Moyamoya Disease with Coexistent Hypertriglyceridemia in Pediatric Patient

Department of Pediatric, Children’s Hospital of the University of Illinois, Chicago, IL, USA

Received 30 June 2016; Revised 15 September 2016; Accepted 26 September 2016

Academic Editor: Osamu Isozaki

Copyright © 2016 Jacqueline Chan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. E. El Tecle, T. Y. El Ahmadieh, A. M. Bohnen, A. D. Nanney, and B. R. Bendok, “Are hyperlipidemia and autoimmune diseases synergistic in moyamoya disease pathophysiology? Insight from the midwest,” World Neurosurgery, vol. 82, no. 1-2, p. e398, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. G. M. Burke, A. M. Burke, A. K. Sherma, M. C. Hurley, H. H. Batjer, and B. R. Bendok, “Moyamoya disease: a summary,” Neurosurgical Focus, vol. 26, no. 4, pp. 1–10, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. W. Miao, P.-L. Zhao, Y.-S. Zhang et al., “Epidemiological and clinical features of Moyamoya disease in Nanjing, China,” Clinical Neurology and Neurosurgery, vol. 112, no. 3, pp. 199–203, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. R. S. Bower, G. W. Mallory, M. Nwojo, Y. C. Kudva, K. D. Flemming, and F. B. Meyer, “Moyamoya disease in a primarily white, Midwestern us population: increased prevalence of autoimmune disease,” Stroke, vol. 44, no. 7, pp. 1997–1999, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Berglund, J. D. Brunzell, A. C. Goldberg et al., “Evaluation and treatment of hypertriglyceridemia: an endocrine society clinical practice guideline,” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 9, pp. 2969–2989, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. C.-C. Hung, Y.-K. Tu, C.-F. Su, L.-S. Lin, and C.-J. Shih, “Epidemiological study of Moyamoya disease in Taiwan,” Clinical Neurology and Neurosurgery, vol. 99, no. 2, pp. S23–S25, 1997. View at Google Scholar · View at Scopus
  7. Y. Yonekawa, J. Fandino, M. Hug, M. Wiesli, M. Fujioka, and N. Khan, Moyamoya Angiopathy in Europe. Moyamoya Disease Update, Springer, Tokyo, Japan, 2010.
  8. H. Fodstad, M. Bodosi, A. Forssell, and D. Perricone, “Moyamoya disease in patients of Finno-Ugric origin,” British Journal of Neurosurgery, vol. 10, no. 2, pp. 179–186, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. A. V. Gaddi, A. F. G. Cicero, F. O. Odoo, A. Poli, and R. Paoletti, “Practical recommendations for familial combined hyperlipidemia diagnosis and management: an update,” Vascular Disease Prevention, vol. 4, no. 3, pp. 229–236, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. Y.-C. Wei, C.-H. Liu, T.-Y. Chang et al., “Coexisting diseases of moyamoya vasculopathy,” Journal of Stroke and Cerebrovascular Diseases, vol. 23, no. 6, pp. 1344–1350, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. R. M. Scott and E. R. Smith, “Moyamoya disease and moyamoya syndrome,” The New England Journal of Medicine, vol. 360, no. 12, pp. 1226–1237, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. J.-I. Takanishi, Moyamoyan Disease in Children, Brain and Development, Elsevier, 2011.
  13. C.-C. Hung, Y.-K. Tu, C.-F. Su, L.-S. Lin, and C.-J. Shih, “Epidemiological study of moyamoya disease in Taiwan,” Clinical Neurology and Neurosurgery, vol. 99, supplement 2, pp. S23–S25, 1997. View at Google Scholar · View at Scopus
  14. S. Kuroda, T. Ishikawa, K. Houkin, R. Nanba, M. Hokari, and Y. Iwasaki, “Incidence and clinical features of disease progression in adult moyamoya disease,” Stroke, vol. 36, no. 10, pp. 2148–2153, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. S. C. Lee, J. S. Jeon, J. E. Kim et al., “Contralateral progression and its risk factor in surgically treated unilateral adult moyamoya disease with a review of pertinent literature,” Acta Neurochirurgica, vol. 156, no. 1, pp. 103–111, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. S. J. Kim, K. G. Heo, H. Y. Shin et al., “Association of thyroid autoantibodies with moyamoya-type cerebrovascular disease: a prospective study,” Stroke, vol. 41, no. 1, pp. 173–176, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. S.-H. Im, C. W. Oh, O. K. Kwon, J. E. Kim, and D. H. Han, “Moyamoya disease associated with Graves disease: special considerations regarding clinical significance and management,” Journal of Neurosurgery, vol. 102, no. 6, pp. 1013–1017, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Mineharu, Y. Takagi, J. C. Takahashi et al., “Rapid progression of unilateral moyamoya disease in a patient with a family history and an RNF213 risk variant,” Cerebrovascular Diseases, vol. 36, no. 2, pp. 155–157, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Kuroda, N. Hashimoto, T. Yoshimoto, Y. Iwasaki, and Research Committee on Moyamoya Disease in Japan, “Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicenter survey in Japan,” Stroke, vol. 38, pp. 1430–1435, 2007. View at Publisher · View at Google Scholar
  20. B. A. Gross and R. Du, “The natural history of Moyamoya in a North American adult cohort,” Journal of Clinical Neuroscience, vol. 20, no. 1, pp. 44–48, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. W.-S. Cho, Y. S. E. Chung, J. E. U. Kim et al., “The natural clinical course of hemodynamically stable adult moyamoya disease,” Journal of Neurosurgery, vol. 122, no. 1, pp. 82–89, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. H. J. Noh, S. J. Kim, J. S. Kim et al., “Long term outcome and predictors of ischemic stroke recurrence in adult moyamoya disease,” Journal of the Neurological Sciences, vol. 359, no. 1-2, pp. 381–388, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Kraemer, P. Berlit, F. Diesner, and N. Khan, “What is the expert's option on antiplatelet therapy in moyamoya disease? Results of a worldwide Survey,” European Journal of Neurology, vol. 19, no. 1, pp. 163–167, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Yamada, K. Oki, Y. Itoh et al., “Effects of surgery and antiplatelet therapy in ten-year follow-up from the registry study of research committee on moyamoya disease in Japan,” Journal of Stroke and Cerebrovascular Diseases, vol. 25, no. 2, pp. 340–349, 2016. View at Publisher · View at Google Scholar
  25. M. Fukui, S. Kono, K. Sueishi, and K. Ikezaki, “Moyamoya disease,” Neuropathology, vol. 20, supplement 1, pp. S61–S64, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. A. M. I. Andeejani, M. A. M. Salih, T. Kolawole et al., “Moyamoya syndrome with unusual angiographic findings and protein C deficiency: review of the literature,” Journal of the Neurological Sciences, vol. 159, no. 1, pp. 11–16, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Cerrato, M. Grasso, A. Lentini et al., “Atherosclerotic adult Moya-Moya disease in a patient with hyperhomocysteinaemia,” Neurological Sciences, vol. 28, no. 1, pp. 45–47, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Booth, R. Yanofsky, I. B. Ross, P. Lawrence, and K. Oen, “Primary antiphospholipid syndrome with moyamoya-like vascular changes,” Pediatric Neurosurgery, vol. 31, no. 1, pp. 45–48, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Tsuda, S. Hattori, S. Tanabe et al., “Thrombophilia found in patients with Moyamoya disease,” Clinical Neurology and Neurosurgery, vol. 99, supplement 2, pp. S229–S233, 1997. View at Google Scholar · View at Scopus
  30. H. C. Jeong, Y. J. Kim, W. Yoon, S. P. Joo, S. S. Lee, and Y. W. Park, “Moyamoya syndrome associated with systemic lupus erythematosus,” Lupus, vol. 17, no. 7, pp. 679–682, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Czartoski, D. Hallam, J. M. Lacy, M. R. Chun, and K. Becker, “Postinfectious vasculopathy with evolution to moyamoya syndrome,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 76, no. 2, pp. 256–259, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. N. J. Ullrich, R. Robertson, D. D. Kinnamon et al., “Moyamoya following cranial irradiation for primary brain tumors in children,” Neurology, vol. 68, no. 12, pp. 932–938, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. S. R. Levine, J. E. Knake, and A. B. Young, “Atypical progressive stroke syndrome associated with oral contraceptives and cigarette use,” Stroke, vol. 18, no. 2, pp. 519–523, 1987. View at Publisher · View at Google Scholar · View at Scopus
  34. J. C. Drees, J. A. Stone, and A. H. B. Wu, “Morbidity involving the hallucinogenic designer amines MDA and 2C-I,” Journal of Forensic Sciences, vol. 54, no. 6, pp. 1485–1487, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. M. S. Tullu, A. V. Advirkar, R. G. Ghildiyal, and S. Tambe, “Familial hypertriglyceridemia,” Indian Journal of Pediatrics, vol. 75, no. 12, pp. 1257–1258, 2008. View at Publisher · View at Google Scholar · View at Scopus